C1q is increased in cerebrospinal fluid‐derived extracellular vesicles in Alzheimer's disease: A multi‐cohort proteomics and immuno‐assay validation study
Alzheimer's & Dementia · 2023
DOI: 10.1002/alz.13066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2023. Verfasst von Madhurima Chatterjee und 16 weiteren Autor:innen. Beteiligte Einrichtung: German Center for Neurodegenerative Diseases, DZNE, Bonn, Germany. Hauptthemen laut MEDLINE: Alzheimer Disease, Extracellular Vesicles, Cognitive Dysfunction. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Demenz
Abstract (Originalsprache)
Introduction
Extracellular vesicles (EVs) may propagate and modulate Alzheimer's disease (AD) pathology. We aimed to comprehensively characterize the proteome of cerebrospinal fluid (CSF) EVs to identify proteins and pathways altered in AD.
Methods
CSF EVs were isolated by ultracentrifugation (Cohort 1) or Vn96 peptide (Cohort 2) from non‐neurodegenerative controls ( n = 15, 16) and AD patients ( n = 22, 20, respectively). EVs were subjected to untargeted quantitative mass spectrometry‐based proteomics. Results were validated by enzyme‐linked immunosorbent assay (ELISA) in Cohorts 3 and 4, consisting of controls ( n = 16, n = 43, (Cohort3, Cohort4)), and patients with AD ( n = 24, n = 100).
Results
We found > 30 differentially expressed proteins in AD CSF EVs involved in immune‐regulation. Increase of C1q levels in AD compared to non‐demented controls was validated by ELISA (∼ 1.5 fold, p (Cohort 3) = 0.03, p (Cohort 4) = 0.005).
Discussion
EVs may be utilized as a potential biomarker and may play a so far unprecedented role in immune‐regulation in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- German Center for Neurodegenerative Diseases, DZNE, Bonn, Germany.
- Department of Psychiatry and Psychotherapy, University Medical Center, Goettingen, Germany.
- Clinical Chemistry Department, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
- Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany.
- OncoProteomics Laboratory, Department Medical Oncology, 1098 XH Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
- Department of Experimental Medicine, Section of Physiology and Biochemistry, University of Perugia, Perugia, Italy.
ORCID-Profile: Anja Schneider
Zitieren
APA
Chatterjee, M., Özdemir, S., Kunadt, M., Koel-Simmelink, M., Boiten, W., Piepkorn, L., Pham, T. V., Chiasserini, D., Piersma, S. R., Knol, J. C., Möbius, W., Mollenhauer, B., van der Flier, W. M., Jimenez, C. R., Teunissen, C. E., Jahn, O., & Schneider, A. (2023). C1q is increased in cerebrospinal fluid‐derived extracellular vesicles in Alzheimer's disease: A multi‐cohort proteomics and immuno‐assay validation study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13066
Vancouver
Chatterjee M, Özdemir S, Kunadt M, Koel-Simmelink M, Boiten W, Piepkorn L, et al. C1q is increased in cerebrospinal fluid‐derived extracellular vesicles in Alzheimer's disease: A multi‐cohort proteomics and immuno‐assay validation study. Alzheimer's & Dementia. 2023. doi:10.1002/alz.13066
BibTeX
@article{Chatterjee2023,
author = {Chatterjee, Madhurima and Özdemir, Selcuk and Kunadt, Marcel and Koel-Simmelink, Marleen and Boiten, Walter and Piepkorn, Lars and Pham, Thang V and Chiasserini, Davide and Piersma, Sander R and Knol, Jaco C and Möbius, Wiebke and Mollenhauer, Brit and van der Flier, Wiesje M and Jimenez, Connie R and Teunissen, Charlotte E and Jahn, Olaf and Schneider, Anja},
title = {C1q is increased in cerebrospinal fluid‐derived extracellular vesicles in Alzheimer's disease: A multi‐cohort proteomics and immuno‐assay validation study},
journal = {Alzheimer's & Dementia},
year = {2023},
doi = {10.1002/alz.13066}
}
EUVIMED